Literature DB >> 14987382

The liver: a model of organ-specific lymphocyte recruitment.

Patricia F Lalor1, David H Adams.   

Abstract

The liver is constantly exposed to gut-derived antigens that enter via the portal vein, and it must modulate immune responses so that harmful pathogens are cleared but necessary food antigens are ignored. The liver contains a large resident and migratory population of lymphocytes and macrophages that provide immune surveillance against foreign antigen. This population of cells can be rapidly expanded in response to infection or injury by recruiting leukocytes from the circulation, a process that is dependent on the ability of lymphocytes to recognise, bind to and migrate across the endothelial cells that line the vasculature. Lymphocytes can enter the liver at several sites: the vascular endothelium in the portal tracts (comprising the hepatic artery, portal vein and bile ductule), the sinusoids (through which the blood percolates past the hepatocytes) or the central hepatic veins (through which the blood exits). The requirements and physical conditions at each site vary and there is evidence that different combinations of adhesion proteins are involved at these different sites. This article discusses the expression and function of adhesion molecules within the liver and demonstrates how specific populations of effector lymphocytes can be selectively recruited to the liver.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14987382     DOI: 10.1017/S1462399402004155

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  15 in total

Review 1.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

Review 2.  Macrophages in hepatitis B and hepatitis C virus infections.

Authors:  Mathis Heydtmann
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

3.  Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro.

Authors:  A L Hepburn; J C Mason; S Wang; C J Shepherd; O Florey; D O Haskard; K A Davies
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  Inhibition of leukocyte adhesion by developmental endothelial locus-1 (del-1).

Authors:  Eun Young Choi
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

5.  Transcriptional profiles of leukocyte populations provide a tool for interpreting gene expression patterns associated with high fat diet in mice.

Authors:  William R Swindell; Andrew Johnston; Johann E Gudjonsson
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

6.  Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis.

Authors:  Savneet Kaur; Sadam Hussain; Kailash Kolhe; Guresh Kumar; Dinesh M Tripathi; Arvind Tomar; Pratibha Kale; Ashad Narayanan; Chaggan Bihari; Meenu Bajpai; Rakhi Maiwall; Ekta Gupta; Shiv K Sarin
Journal:  JHEP Rep       Date:  2021-05-08

Review 7.  Innate immune cells in liver inflammation.

Authors:  Evaggelia Liaskou; Daisy V Wilson; Ye H Oo
Journal:  Mediators Inflamm       Date:  2012-08-09       Impact factor: 4.711

8.  Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).

Authors:  Roberto De Pascalis; Alicia Y Chou; Patrik Ryden; Nikki J Kennett; Anders Sjöstedt; Karen L Elkins
Journal:  mBio       Date:  2014-04-08       Impact factor: 7.867

9.  Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis.

Authors:  Yung-Yi Chen; Hannah C Jeffery; Stuart Hunter; Ricky Bhogal; Jane Birtwistle; Manjit Kaur Braitch; Sheree Roberts; Mikaela Ming; Jack Hannah; Clare Thomas; Gupse Adali; Stefan G Hübscher; Wing-Kin Syn; Simon Afford; Patricia F Lalor; David H Adams; Ye H Oo
Journal:  Hepatology       Date:  2016-04-15       Impact factor: 17.425

10.  CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma.

Authors:  James C R Wadkin; Daniel A Patten; Sivesh K Kamarajah; Emma L Shepherd; Vera Novitskaya; Fedor Berditchevski; David H Adams; Chris J Weston; Shishir Shetty
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.